Go Pro
→ Nvidia's CEO says this small device is critical for AI growth (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$26.67
-1.4%		$23.02
$15.73
▼
$30.00
$13.82B0.67.90 million shs4.96 million shs
LivaNova PLC stock logo
LIVN
LivaNova
$82.22
+0.0%		$80.36
$48.82
▼
$85.76
$4.53B0.86701,035 shs559,433 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$326.91
+0.0%		$319.53
$221.26
▼
$362.41
$12.88B0.7353,121 shs251,606 shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$29.84
-0.9%		$30.45
$28.56
▼
$38.79
$12.60B0.551.67 million shs1.07 million shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
0.00%-2.91%+14.16%+54.18%+10.55%
LivaNova PLC stock logo
LIVN
LivaNova
0.00%+7.87%+0.53%+17.46%+54.96%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%+0.69%+2.36%+1.45%+26.87%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.00%-0.89%-5.01%+0.95%-18.90%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$26.67
-1.4%		$23.02
$15.73
▼
$30.00
$13.82B0.67.90 million shs4.96 million shs
LivaNova PLC stock logo
LIVN
LivaNova
$82.22
+0.0%		$80.36
$48.82
▼
$85.76
$4.53B0.86701,035 shs559,433 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$326.91
+0.0%		$319.53
$221.26
▼
$362.41
$12.88B0.7353,121 shs251,606 shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$29.84
-0.9%		$30.45
$28.56
▼
$38.79
$12.60B0.551.67 million shs1.07 million shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
0.00%-2.91%+14.16%+54.18%+10.55%
LivaNova PLC stock logo
LIVN
LivaNova
0.00%+7.87%+0.53%+17.46%+54.96%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%+0.69%+2.36%+1.45%+26.87%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.00%-0.89%-5.01%+0.95%-18.90%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.00
Hold$22.45-15.79% Downside
LivaNova PLC stock logo
LIVN
LivaNova
2.73
Moderate Buy$83.501.56% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.12
Hold$367.0712.29% Upside
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.00
Hold$30.933.65% Upside

Current Analyst Ratings Breakdown

Latest LIVN, BAX, PEN, and SNN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2026
Baxter International Inc. stock logo
BAX
Baxter International
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/7/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
8/6/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight ➝ Neutral
8/5/2026
LivaNova PLC stock logo
LIVN
LivaNova
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$85.00
8/5/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
8/5/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeEqual Weight ➝ Underweight
8/5/2026
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$81.00 ➝ $93.00
8/4/2026
LivaNova PLC stock logo
LIVN
LivaNova
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
7/31/2026
Baxter International Inc. stock logo
BAX
Baxter International
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D-) ➝ Sell (D)
7/31/2026
Baxter International Inc. stock logo
BAX
Baxter International
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$19.00 ➝ $23.00
7/31/2026
Baxter International Inc. stock logo
BAX
Baxter International
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell ➝ Neutral$17.00 ➝ $28.00
(Data available from 8/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$11.47B1.20$5.67 per share4.70$11.95 per share2.23
LivaNova PLC stock logo
LIVN
LivaNova
$1.39B3.26$4.84 per share17.00$24.06 per share3.42
Penumbra, Inc. stock logo
PEN
Penumbra
$1.50B8.56$4.30 per share76.07$38.86 per share8.41
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$6.16B2.05$3.43 per share8.69$12.26 per share2.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
-$957M-$2.07N/A13.404.05-9.27%16.57%5.24%10/29/2026 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$3.3824.3319.86N/A12.82%16.35%7.76%11/4/2026 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$177.69M$4.0780.3252.642.0310.67%10.50%8.17%11/4/2026 (Estimated)
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$625MN/AN/A12.541.10N/AN/AN/AN/A

Latest LIVN, BAX, PEN, and SNN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
LivaNova PLC stock logo
LIVN
LivaNova
$1.09$1.26+$0.17$1.93$380.50 million$390.59 million
7/30/2026Q2 2026
Baxter International Inc. stock logo
BAX
Baxter International
$0.3665$0.56+$0.1935$0.24$2.80 billion$2.96 billion
7/30/2026Q2 2026
Penumbra, Inc. stock logo
PEN
Penumbra
$1.16$0.88-$0.28$0.88$389.64 million$390.05 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$0.040.15%-11.54%N/A N/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.933.12%N/AN/AN/A

Latest LIVN, BAX, PEN, and SNN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/4/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.31202.05%10/2/202610/2/202611/6/2026
7/29/2026
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.010.15%8/28/20268/28/202610/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.39
1.95
1.32
LivaNova PLC stock logo
LIVN
LivaNova
0.22
1.45
1.21
Penumbra, Inc. stock logo
PEN
Penumbra
0.01
5.75
3.86
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.62
2.14
1.11

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
25.64%

Insider Ownership

CompanyInsider Ownership
Baxter International Inc. stock logo
BAX
Baxter International
0.17%
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
Penumbra, Inc. stock logo
PEN
Penumbra
2.90%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
37,500517.00 million516.12 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30055.09 million54.90 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,70039.39 million38.25 millionOptionable
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
16,988422.52 million418.29 millionOptionable

Recent News About These Companies

Smith & Nephew SNATS (NYSE:SNN) Lowered to Hold Rating by Wall Street Zen
August 16 at 1:06 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30963044
Smith & Nephew SNATS (NYSE:SNN) Stock Rating Lowered by Wall Street Zen
August 16 at 1:05 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/smith-nephew-snats-nysesnn-stock-rating-lowered-by-wall-street-zen-2026-08-16/
Smith & Nephew SNATS, Inc. $SNN Shares Sold by Bank of America Corp DE
August 14 at 3:20 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-smith-nephew-snats-inc-snn-shares-sold-by-bank-of-america-corp-de-2026-08-14/
Smith & Nephew SNATS Q2 Earnings Call Highlights
August 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/smith-nephew-snats-q2-earnings-call-highlights-2026-08-09/
Smith & Nephew SNATS (NYSE:SNN) Earns "Neutral" Rating from JPMorgan Chase & Co.
August 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30948259
Wall Street Zen Downgrades Smith & Nephew SNATS (NYSE:SNN) to Buy
August 8, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30947312
Smith & Nephew SNATS (NYSE:SNN) Lowered to "Buy" Rating by Wall Street Zen
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/smith-nephew-snats-nysesnn-lowered-to-buy-rating-by-wall-street-zen-2026-08-08/
Smith & Nephew Snats Earnings Call: Profits Overcome Drag
August 6, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/SNN-N/pressreleases/3679758/smith-nephew-snats-earnings-call-profits-overcome-drag/
Smith & Nephew SNATS's (SNN) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co.
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/smith-nephew-snatss-snn-neutral-rating-reaffirmed-at-jpmorgan-chase-co-2026-08-06/
Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339572/0/en/smith-nephew-celebrates-mobility-recovery-and-football-s-greatest-traditions-during-pro-football-hall-of-fame-enshrinement-week.html
Smith & Nephew SNATS, Inc. Announces Dividend of $0.31 (NYSE:SNN)
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/smith-nephew-snats-inc-announces-dividend-of-031-nysesnn-2026-08-05/
Quantinno Capital Management LP Buys 88,068 Shares of Smith & Nephew SNATS, Inc. $SNN
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-quantinno-capital-management-lp-buys-88068-shares-of-smith-nephew-snats-inc-snn-2026-08-05/
Smith & Nephew SNATS, Inc. $SNN Stake Raised by Dimensional Fund Advisors LP
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-smith-nephew-snats-inc-snn-stake-raised-by-dimensional-fund-advisors-lp-2026-08-05/
Smith & Nephew plc 2026 Q2 - Results - Earnings Call Presentation
August 4, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4930125-smith-and-nephew-plc-2026-q2-results-earnings-call-presentation
Smith & Nephew SNATS (NYSE:SNN) Announces Quarterly Earnings Results, Misses Estimates By $0.46 EPS
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/smith-nephew-snats-nysesnn-announces-quarterly-earnings-results-misses-estimates-by-046-eps-2026-08-04/
Smith & Nephew SNATS (NYSE:SNN) Trading Down 5.8% on Disappointing Earnings
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/smith-nephew-snats-nysesnn-trading-down-58-on-disappointing-earnings-2026-08-04/
Smith & Nephew cuts sales outlook after weak US trading
August 4, 2026  |  proactiveinvestors.co.ukhttps://www.proactiveinvestors.co.uk/companies/news/1096475?snapi
Smith & Nephew SNATS, Inc. (NYSE:SNN) Receives Consensus Recommendation of "Hold" from Brokerages
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/smith-nephew-snats-inc-nysesnn-receives-consensus-recommendation-of-hold-from-brokerages-2026-08-03/
Smith & Nephew SNATS, Inc. $SNN Stock Position Lowered by Arrowstreet Capital Limited Partnership
August 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-smith-nephew-snats-inc-snn-stock-position-lowered-by-arrowstreet-capital-limited-partnership-2026-08-01/
Smith & Nephew SNATS (SNN) to Announce Quarterly Earnings on Tuesday
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/smith-nephew-snats-snn-to-announce-quarterly-earnings-on-tuesday-2026-07-28/
Smith+Nephew Expands ASC Platform to Support Value-Based Care
July 23, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2959634/smith-nephew-expands-asc-platform-to-support-value-based-care?cid=cs-stocknewsapi-ft-analyst_blog|company_news_medical_sector-2959634

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AMD logo on a glowing processor chip with red circuit traces, highlighting AI and data-center semiconductor demand.
AMD’s AI Bubble Could Burst Into Explosive Upside
By Thomas Hughes | July 27, 2026
Trading screen displaying a candlestick price chart, options calls and puts pricing table, and green call, red put buttons.
The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
By Bridget Bennett | July 20, 2026
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
Microsoft logo displayed on a wall-mounted plaque in a modern office lobby with glass partitions.
Microsoft Just Flipped the AI Spending Narrative Overnight
By Chris Markoch | July 30, 2026
Amazon-branded package carried by a delivery drone inside a warehouse, highlighting Amazon logistics and tech momentum.
Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
By Sam Quirke | July 31, 2026
Baxter International stock logo

Baxter International NYSE:BAX

$26.66 -0.39 (-1.42%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$26.65 -0.02 (-0.06%)
As of 08/14/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$82.22 +0.02 (+0.02%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$82.20 -0.02 (-0.02%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Penumbra stock logo

Penumbra NYSE:PEN

$326.91 +0.16 (+0.05%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$326.00 -0.91 (-0.28%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Smith & Nephew SNATS stock logo

Smith & Nephew SNATS NYSE:SNN

$29.84 -0.28 (-0.91%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$29.88 +0.04 (+0.13%)
As of 08/14/2026 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas